Loading…
Upgrading and Downgrading of Prostate Cancer from Biopsy to Radical Prostatectomy: Incidence and Predictive Factors Using the Modified Gleason Grading System and Factoring in Tertiary Grades
Abstract Background Prior studies assessing the correlation of Gleason score (GS) at needle biopsy and corresponding radical prostatectomy (RP) predated the use of the modified Gleason scoring system and did not factor in tertiary grade patterns. Objective To assess the relation of biopsy and RP gra...
Saved in:
Published in: | European urology 2012-05, Vol.61 (5), p.1019-1024 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c613t-eb1b53df2cd4dfdb73ca188eb6695deb97cdb8cf685b59c6ba3e03ba6f1cc5883 |
---|---|
cites | cdi_FETCH-LOGICAL-c613t-eb1b53df2cd4dfdb73ca188eb6695deb97cdb8cf685b59c6ba3e03ba6f1cc5883 |
container_end_page | 1024 |
container_issue | 5 |
container_start_page | 1019 |
container_title | European urology |
container_volume | 61 |
creator | Epstein, Jonathan I Feng, Zhaoyong Trock, Bruce J Pierorazio, Phillip M |
description | Abstract Background Prior studies assessing the correlation of Gleason score (GS) at needle biopsy and corresponding radical prostatectomy (RP) predated the use of the modified Gleason scoring system and did not factor in tertiary grade patterns. Objective To assess the relation of biopsy and RP grade in the largest study to date. Design, setting, and participants A total of 7643 totally embedded RP and corresponding needle biopsies (2004–2010) were analyzed according to the updated Gleason system. Interventions All patients underwent prostate biopsy prior to RP. Measurements The relation of upgrading or downgrading to patient and cancer characteristics was compared using the chi-square test, Student t test, and multivariable logistic regression. Results and limitations A total of 36.3% of cases were upgraded from a needle biopsy GS 5–6 to a higher grade at RP (11.2% with GS 6 plus tertiary). Half of the cases had matching GS 3 + 4 = 7 at biopsy and RP with an approximately equal number of cases downgraded and upgraded at RP. With biopsy GS 4 + 3 = 7, RP GS was almost equally 3 + 4 = 7 and 4 + 3 = 7. Biopsy GS 8 led to an almost equal distribution between RP GS 4 + 3 = 7, 8, and 9–10. A total of 58% of the cases had matching GS 9–10 at biopsy and RP. In multivariable analysis, increasing age ( p < 0.0001), increasing serum prostate-specific antigen level ( p < 0.0001), decreasing RP weight ( p < 0.0001), and increasing maximum percentage cancer/core ( p < 0.0001) predicted the upgrade from biopsy GS 5–6 to higher at RP. Despite factoring in multiple variables including the number of positive cores and the maximum percentage of cancer per core, the concordance indexes were not sufficiently high to justify the use of nomograms for predicting upgrading and downgrading for the individual patient. Conclusions Almost 20% of RP cases have tertiary patterns. A needle biopsy can sample a tertiary higher Gleason pattern in the RP, which is then not recorded in the standard GS reporting, resulting in an apparent overgrading on the needle biopsy. |
doi_str_mv | 10.1016/j.eururo.2012.01.050 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4659370</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0302283812001686</els_id><sourcerecordid>964200573</sourcerecordid><originalsourceid>FETCH-LOGICAL-c613t-eb1b53df2cd4dfdb73ca188eb6695deb97cdb8cf685b59c6ba3e03ba6f1cc5883</originalsourceid><addsrcrecordid>eNqFks2O0zAUhSMEYsrAGyDkDWKVYMeN47JAgsKUkQYxYqZry7FvOi6JXWynqC_Hs-G0nfKzYRUl_s7xzTk3y54TXBBM2Ot1AYMfvCtKTMoCkwJX-EE2IbymeV0x_DCbYIrLvOSUn2VPQlhjjGk1o4-zs7KklFGOJ9nP5WblpTZ2haTV6IP7Ye_fXYuuvQtRRkBzaRV41HrXo_fGbcIORYe-JlDJ7oSp6PrdG3RpldGQBHvLaw-JimYL6EImwge0DKN_vAP02WnTGtBo0YEMzqLF8fKbXYjQ7w0OqvGjsegWfDTS7_YghKfZo1Z2AZ4dn-fZ8uLj7fxTfvVlcTl_d5UrRmjMoSFNRXVbKj3VrW5qqiThHBrGZpWGZlYr3XDVMl411UyxRlLAtJGsJUpVnNPz7O3BdzM0PWgFNnrZiY03fRpGOGnE3yfW3ImV24opS4nXOBm8Ohp4932AEEVvgoKukxbcEMSMTUuMq5omcnogVUo1eGhPtxAsxubFWhyaF2PzAhORmk-yF39OeBLdV52Al0dAhlRa61OlJvzmqppxnNI6_SqkPLcGvAjKjG1q41PDQjvzv0n-NVCdseOifIMdhLUbvE1dCSJC0oibcUvHJSUpAMI4o78A7VTpyQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>964200573</pqid></control><display><type>article</type><title>Upgrading and Downgrading of Prostate Cancer from Biopsy to Radical Prostatectomy: Incidence and Predictive Factors Using the Modified Gleason Grading System and Factoring in Tertiary Grades</title><source>ScienceDirect Freedom Collection</source><creator>Epstein, Jonathan I ; Feng, Zhaoyong ; Trock, Bruce J ; Pierorazio, Phillip M</creator><creatorcontrib>Epstein, Jonathan I ; Feng, Zhaoyong ; Trock, Bruce J ; Pierorazio, Phillip M</creatorcontrib><description>Abstract Background Prior studies assessing the correlation of Gleason score (GS) at needle biopsy and corresponding radical prostatectomy (RP) predated the use of the modified Gleason scoring system and did not factor in tertiary grade patterns. Objective To assess the relation of biopsy and RP grade in the largest study to date. Design, setting, and participants A total of 7643 totally embedded RP and corresponding needle biopsies (2004–2010) were analyzed according to the updated Gleason system. Interventions All patients underwent prostate biopsy prior to RP. Measurements The relation of upgrading or downgrading to patient and cancer characteristics was compared using the chi-square test, Student t test, and multivariable logistic regression. Results and limitations A total of 36.3% of cases were upgraded from a needle biopsy GS 5–6 to a higher grade at RP (11.2% with GS 6 plus tertiary). Half of the cases had matching GS 3 + 4 = 7 at biopsy and RP with an approximately equal number of cases downgraded and upgraded at RP. With biopsy GS 4 + 3 = 7, RP GS was almost equally 3 + 4 = 7 and 4 + 3 = 7. Biopsy GS 8 led to an almost equal distribution between RP GS 4 + 3 = 7, 8, and 9–10. A total of 58% of the cases had matching GS 9–10 at biopsy and RP. In multivariable analysis, increasing age ( p < 0.0001), increasing serum prostate-specific antigen level ( p < 0.0001), decreasing RP weight ( p < 0.0001), and increasing maximum percentage cancer/core ( p < 0.0001) predicted the upgrade from biopsy GS 5–6 to higher at RP. Despite factoring in multiple variables including the number of positive cores and the maximum percentage of cancer per core, the concordance indexes were not sufficiently high to justify the use of nomograms for predicting upgrading and downgrading for the individual patient. Conclusions Almost 20% of RP cases have tertiary patterns. A needle biopsy can sample a tertiary higher Gleason pattern in the RP, which is then not recorded in the standard GS reporting, resulting in an apparent overgrading on the needle biopsy.</description><identifier>ISSN: 0302-2838</identifier><identifier>EISSN: 1873-7560</identifier><identifier>DOI: 10.1016/j.eururo.2012.01.050</identifier><identifier>PMID: 22336380</identifier><identifier>CODEN: EUURAV</identifier><language>eng</language><publisher>Kidlington: Elsevier B.V</publisher><subject>Adult ; Age Factors ; Aged ; Biological and medical sciences ; Biopsy, Needle ; Gleason grade ; Gynecology. Andrology. Obstetrics ; Humans ; Male ; Male genital diseases ; Medical sciences ; Middle Aged ; Needle biopsy ; Neoplasm Grading ; Nephrology. Urinary tract diseases ; Nomograms ; Prostate-Specific Antigen - blood ; Prostatectomy - methods ; Prostatic Neoplasms - pathology ; Prostatic Neoplasms - surgery ; Radical prostatectomy ; Risk Factors ; Tumors ; Tumors of the urinary system ; Urinary tract. Prostate gland ; Urology</subject><ispartof>European urology, 2012-05, Vol.61 (5), p.1019-1024</ispartof><rights>European Association of Urology</rights><rights>2012 European Association of Urology</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2012 European Association of Urology. Published by Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c613t-eb1b53df2cd4dfdb73ca188eb6695deb97cdb8cf685b59c6ba3e03ba6f1cc5883</citedby><cites>FETCH-LOGICAL-c613t-eb1b53df2cd4dfdb73ca188eb6695deb97cdb8cf685b59c6ba3e03ba6f1cc5883</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25768061$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22336380$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Epstein, Jonathan I</creatorcontrib><creatorcontrib>Feng, Zhaoyong</creatorcontrib><creatorcontrib>Trock, Bruce J</creatorcontrib><creatorcontrib>Pierorazio, Phillip M</creatorcontrib><title>Upgrading and Downgrading of Prostate Cancer from Biopsy to Radical Prostatectomy: Incidence and Predictive Factors Using the Modified Gleason Grading System and Factoring in Tertiary Grades</title><title>European urology</title><addtitle>Eur Urol</addtitle><description>Abstract Background Prior studies assessing the correlation of Gleason score (GS) at needle biopsy and corresponding radical prostatectomy (RP) predated the use of the modified Gleason scoring system and did not factor in tertiary grade patterns. Objective To assess the relation of biopsy and RP grade in the largest study to date. Design, setting, and participants A total of 7643 totally embedded RP and corresponding needle biopsies (2004–2010) were analyzed according to the updated Gleason system. Interventions All patients underwent prostate biopsy prior to RP. Measurements The relation of upgrading or downgrading to patient and cancer characteristics was compared using the chi-square test, Student t test, and multivariable logistic regression. Results and limitations A total of 36.3% of cases were upgraded from a needle biopsy GS 5–6 to a higher grade at RP (11.2% with GS 6 plus tertiary). Half of the cases had matching GS 3 + 4 = 7 at biopsy and RP with an approximately equal number of cases downgraded and upgraded at RP. With biopsy GS 4 + 3 = 7, RP GS was almost equally 3 + 4 = 7 and 4 + 3 = 7. Biopsy GS 8 led to an almost equal distribution between RP GS 4 + 3 = 7, 8, and 9–10. A total of 58% of the cases had matching GS 9–10 at biopsy and RP. In multivariable analysis, increasing age ( p < 0.0001), increasing serum prostate-specific antigen level ( p < 0.0001), decreasing RP weight ( p < 0.0001), and increasing maximum percentage cancer/core ( p < 0.0001) predicted the upgrade from biopsy GS 5–6 to higher at RP. Despite factoring in multiple variables including the number of positive cores and the maximum percentage of cancer per core, the concordance indexes were not sufficiently high to justify the use of nomograms for predicting upgrading and downgrading for the individual patient. Conclusions Almost 20% of RP cases have tertiary patterns. A needle biopsy can sample a tertiary higher Gleason pattern in the RP, which is then not recorded in the standard GS reporting, resulting in an apparent overgrading on the needle biopsy.</description><subject>Adult</subject><subject>Age Factors</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Biopsy, Needle</subject><subject>Gleason grade</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Male</subject><subject>Male genital diseases</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Needle biopsy</subject><subject>Neoplasm Grading</subject><subject>Nephrology. Urinary tract diseases</subject><subject>Nomograms</subject><subject>Prostate-Specific Antigen - blood</subject><subject>Prostatectomy - methods</subject><subject>Prostatic Neoplasms - pathology</subject><subject>Prostatic Neoplasms - surgery</subject><subject>Radical prostatectomy</subject><subject>Risk Factors</subject><subject>Tumors</subject><subject>Tumors of the urinary system</subject><subject>Urinary tract. Prostate gland</subject><subject>Urology</subject><issn>0302-2838</issn><issn>1873-7560</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNqFks2O0zAUhSMEYsrAGyDkDWKVYMeN47JAgsKUkQYxYqZry7FvOi6JXWynqC_Hs-G0nfKzYRUl_s7xzTk3y54TXBBM2Ot1AYMfvCtKTMoCkwJX-EE2IbymeV0x_DCbYIrLvOSUn2VPQlhjjGk1o4-zs7KklFGOJ9nP5WblpTZ2haTV6IP7Ye_fXYuuvQtRRkBzaRV41HrXo_fGbcIORYe-JlDJ7oSp6PrdG3RpldGQBHvLaw-JimYL6EImwge0DKN_vAP02WnTGtBo0YEMzqLF8fKbXYjQ7w0OqvGjsegWfDTS7_YghKfZo1Z2AZ4dn-fZ8uLj7fxTfvVlcTl_d5UrRmjMoSFNRXVbKj3VrW5qqiThHBrGZpWGZlYr3XDVMl411UyxRlLAtJGsJUpVnNPz7O3BdzM0PWgFNnrZiY03fRpGOGnE3yfW3ImV24opS4nXOBm8Ohp4932AEEVvgoKukxbcEMSMTUuMq5omcnogVUo1eGhPtxAsxubFWhyaF2PzAhORmk-yF39OeBLdV52Al0dAhlRa61OlJvzmqppxnNI6_SqkPLcGvAjKjG1q41PDQjvzv0n-NVCdseOifIMdhLUbvE1dCSJC0oibcUvHJSUpAMI4o78A7VTpyQ</recordid><startdate>20120501</startdate><enddate>20120501</enddate><creator>Epstein, Jonathan I</creator><creator>Feng, Zhaoyong</creator><creator>Trock, Bruce J</creator><creator>Pierorazio, Phillip M</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20120501</creationdate><title>Upgrading and Downgrading of Prostate Cancer from Biopsy to Radical Prostatectomy: Incidence and Predictive Factors Using the Modified Gleason Grading System and Factoring in Tertiary Grades</title><author>Epstein, Jonathan I ; Feng, Zhaoyong ; Trock, Bruce J ; Pierorazio, Phillip M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c613t-eb1b53df2cd4dfdb73ca188eb6695deb97cdb8cf685b59c6ba3e03ba6f1cc5883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adult</topic><topic>Age Factors</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Biopsy, Needle</topic><topic>Gleason grade</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Male</topic><topic>Male genital diseases</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Needle biopsy</topic><topic>Neoplasm Grading</topic><topic>Nephrology. Urinary tract diseases</topic><topic>Nomograms</topic><topic>Prostate-Specific Antigen - blood</topic><topic>Prostatectomy - methods</topic><topic>Prostatic Neoplasms - pathology</topic><topic>Prostatic Neoplasms - surgery</topic><topic>Radical prostatectomy</topic><topic>Risk Factors</topic><topic>Tumors</topic><topic>Tumors of the urinary system</topic><topic>Urinary tract. Prostate gland</topic><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Epstein, Jonathan I</creatorcontrib><creatorcontrib>Feng, Zhaoyong</creatorcontrib><creatorcontrib>Trock, Bruce J</creatorcontrib><creatorcontrib>Pierorazio, Phillip M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>European urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Epstein, Jonathan I</au><au>Feng, Zhaoyong</au><au>Trock, Bruce J</au><au>Pierorazio, Phillip M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Upgrading and Downgrading of Prostate Cancer from Biopsy to Radical Prostatectomy: Incidence and Predictive Factors Using the Modified Gleason Grading System and Factoring in Tertiary Grades</atitle><jtitle>European urology</jtitle><addtitle>Eur Urol</addtitle><date>2012-05-01</date><risdate>2012</risdate><volume>61</volume><issue>5</issue><spage>1019</spage><epage>1024</epage><pages>1019-1024</pages><issn>0302-2838</issn><eissn>1873-7560</eissn><coden>EUURAV</coden><abstract>Abstract Background Prior studies assessing the correlation of Gleason score (GS) at needle biopsy and corresponding radical prostatectomy (RP) predated the use of the modified Gleason scoring system and did not factor in tertiary grade patterns. Objective To assess the relation of biopsy and RP grade in the largest study to date. Design, setting, and participants A total of 7643 totally embedded RP and corresponding needle biopsies (2004–2010) were analyzed according to the updated Gleason system. Interventions All patients underwent prostate biopsy prior to RP. Measurements The relation of upgrading or downgrading to patient and cancer characteristics was compared using the chi-square test, Student t test, and multivariable logistic regression. Results and limitations A total of 36.3% of cases were upgraded from a needle biopsy GS 5–6 to a higher grade at RP (11.2% with GS 6 plus tertiary). Half of the cases had matching GS 3 + 4 = 7 at biopsy and RP with an approximately equal number of cases downgraded and upgraded at RP. With biopsy GS 4 + 3 = 7, RP GS was almost equally 3 + 4 = 7 and 4 + 3 = 7. Biopsy GS 8 led to an almost equal distribution between RP GS 4 + 3 = 7, 8, and 9–10. A total of 58% of the cases had matching GS 9–10 at biopsy and RP. In multivariable analysis, increasing age ( p < 0.0001), increasing serum prostate-specific antigen level ( p < 0.0001), decreasing RP weight ( p < 0.0001), and increasing maximum percentage cancer/core ( p < 0.0001) predicted the upgrade from biopsy GS 5–6 to higher at RP. Despite factoring in multiple variables including the number of positive cores and the maximum percentage of cancer per core, the concordance indexes were not sufficiently high to justify the use of nomograms for predicting upgrading and downgrading for the individual patient. Conclusions Almost 20% of RP cases have tertiary patterns. A needle biopsy can sample a tertiary higher Gleason pattern in the RP, which is then not recorded in the standard GS reporting, resulting in an apparent overgrading on the needle biopsy.</abstract><cop>Kidlington</cop><pub>Elsevier B.V</pub><pmid>22336380</pmid><doi>10.1016/j.eururo.2012.01.050</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0302-2838 |
ispartof | European urology, 2012-05, Vol.61 (5), p.1019-1024 |
issn | 0302-2838 1873-7560 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4659370 |
source | ScienceDirect Freedom Collection |
subjects | Adult Age Factors Aged Biological and medical sciences Biopsy, Needle Gleason grade Gynecology. Andrology. Obstetrics Humans Male Male genital diseases Medical sciences Middle Aged Needle biopsy Neoplasm Grading Nephrology. Urinary tract diseases Nomograms Prostate-Specific Antigen - blood Prostatectomy - methods Prostatic Neoplasms - pathology Prostatic Neoplasms - surgery Radical prostatectomy Risk Factors Tumors Tumors of the urinary system Urinary tract. Prostate gland Urology |
title | Upgrading and Downgrading of Prostate Cancer from Biopsy to Radical Prostatectomy: Incidence and Predictive Factors Using the Modified Gleason Grading System and Factoring in Tertiary Grades |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T05%3A25%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Upgrading%20and%20Downgrading%20of%20Prostate%20Cancer%20from%20Biopsy%20to%20Radical%20Prostatectomy:%20Incidence%20and%20Predictive%20Factors%20Using%20the%20Modified%20Gleason%20Grading%20System%20and%20Factoring%20in%20Tertiary%20Grades&rft.jtitle=European%20urology&rft.au=Epstein,%20Jonathan%20I&rft.date=2012-05-01&rft.volume=61&rft.issue=5&rft.spage=1019&rft.epage=1024&rft.pages=1019-1024&rft.issn=0302-2838&rft.eissn=1873-7560&rft.coden=EUURAV&rft_id=info:doi/10.1016/j.eururo.2012.01.050&rft_dat=%3Cproquest_pubme%3E964200573%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c613t-eb1b53df2cd4dfdb73ca188eb6695deb97cdb8cf685b59c6ba3e03ba6f1cc5883%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=964200573&rft_id=info:pmid/22336380&rfr_iscdi=true |